Skip to Main Content

Paper Details

RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer.
Nat Commun
4
2021
ADC, HER2, HER2-positive cell lines, RAB5A, T-DM1, breast cancer, paclitaxel, patients, pertuzumab, trastuzumab, trastuzumab emtansine
Author NameAffiliation
Christina YauUniversity of California San Francisco
Christina YauUniversity of California San Francisco
Kristian BergInstitute for Cancer Research, Oslo University Hospital
Kristian BergDepartment of Pharmacy, University of Oslo
Laura J Van't VeerUniversity of California San Francisco
  • 1 - 5

Datasets

Release 1.2